Adriana Buskin,Lili Zhu,Valeria Chichagova,Basudha Basu,Sina Mozaffari-Jovin,David Dolan,Alastair Droop,Joseph Collin,Revital Bronstein,Sudeep Mehrotra,Michael Farkas,Gerrit Hilgen,Kathryn White,Dean Hallam,Katarzyna Bialas,Git Chung,Carla Mellough,Yuchun Ding,Natalio Krasnogor,Stefan Przyborski,Jumana Al-Aama,Sameer Alharthi,Yaobo Xu,Gabrielle Wheway,Katarzyna Szymanska,Martin McKibbin,Chris F Inglehearn,David J Elliott,Susan Lindsay,Robin R Ali,David H Steel,Lyle Armstrong,Evelyne Sernagor,Eric Pierce,Reinhard Lüehrmann,Sushma-Nagaraja Grellscheid,Colin A Johnson,Majlinda Lako

Abstract:Summary Mutations in pre-mRNA processing factors (PRPFs) cause 40% of autosomal dominant retinitis pigmentosa (RP), but it is unclear why mutations in ubiquitously expressed PRPFs cause retinal disease. To understand the molecular basis of this phenotype, we have generated RP type 11 (PRPF31- mutated) patient-specific retinal organoids and retinal pigment epithelium (RPE) from induced pluripotent stem cells (iPSC). Impaired alternative splicing of genes encoding pre-mRNA splicing proteins occurred in patient-specific retinal cells and Prpf31 +/− mouse retinae, but not fibroblasts and iPSCs, providing mechanistic insights into retinal-specific phenotypes of PRPFs. RPE was the most affected, characterised by loss of apical-basal polarity, reduced trans-epithelial resistance, phagocytic capacity, microvilli, and cilia length and incidence. Disrupted cilia morphology was observed in patient-derived-photoreceptors that displayed progressive features associated with degeneration and cell stress. In situ gene-editing of a pathogenic mutation rescued key structural and functional phenotypes in RPE and photoreceptors, providing proof-of-concept for future therapeutic strategies. eTOC PRPF31 is a ubiquitously expressed pre-mRNA processing factor that when mutated causes autosomal dominant RP. Using a patient-specific iPSC approach, Buskin and Zhu et al. show that retinal-specific defects result from altered splicing of genes involved in the splicing process itself, leading to impaired splicing, loss of RPE polarity and diminished phagocytic ability as well as reduced cilia incidence and length in both photoreceptors and RPE. Highlights Successful generation of iPSC-derived RPE and photoreceptors from four RP type 11 patients RPE cells express the mutant PRPF31 protein and show the lowest expression of wildtype protein PRPF31 mutations result in altered splicing of genes involved in pre-mRNA splicing in RPE and retinal organoids Prpf31 haploinsufficiency results in altered splicing of genes involved in pre-mRNA splicing in mouse retina RPE cells display loss of polarity, reduced barrier function and phagocytosis Photoreceptors display shorter and fewer cilia and degenerative features RPE cells display most abnormalities suggesting they might be the primary site of pathogenesis In situ gene editing corrects the mutation and rescues key phenotypes

Cellular expression and siRNA-mediated interference of rhodopsin cis-acting splicing mutants associated with autosomal dominant retinitis pigmentosa

Transcriptional expression of cis-acting and trans-acting splicing mutations cause autosomal dominant retinitis pigmentosa

Modeling of autosomal-dominant retinitis pigmentosa in Caenorhabditis elegans uncovers a nexus between global impaired functioning of certain splicing factors and cell type-specific apoptosis

Retinitis Pigmentosa Alleles, in PRPF31 and PRPF6, Effects on Pre‐Messenger RNA Splicing

Pre-mRNA Processing Factors and Retinitis Pigmentosa: RNA Splicing and Beyond

RNA-Seq Analysis for Exploring the Pathogenesis of Retinitis Pigmentosa in P23H Knock-In Mice

Temporal and tissue specific regulation of RP-associated splicing factor genes PRPF3, PRPF31 and PRPC8--implications in the pathogenesis of RP

Mutant PRPF8 Causes Widespread Splicing Changes in Spliceosome Components in Retinitis Pigmentosa Patient iPSC-Derived RPE Cells

Disease modeling and pharmacological rescue of autosomal dominant retinitis pigmentosa associated with RHO copy number variation

Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice

Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa

Mutations in the pre-mRNA splicing-factor genes PRPF3, PRPF8, and PRPF31 in Spanish families with autosomal dominant retinitis pigmentosa

Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3

Allele-specific CRISPR/Cas9 genome editing of the single-base P23H mutation for rhodopsin associated dominant retinitis pigmentosa

A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31

CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa

Antisense Oligonucleotide-Based Downregulation of the G56R Pathogenic Variant Causing NR2E3-Associated Autosomal Dominant Retinitis Pigmentosa

Human iPSC-derived RPE and retinal organoids reveal impaired alternative splicing of genes involved in pre-mRNA splicing in PRPF31 autosomal dominant retinitis pigmentosa

A Combined in silico, in vitro and Clinical Approach to Characterize Novel Pathogenic Missense Variants in PRPF31 in Retinitis Pigmentosa

Mutation analysis of pre-mRNA splicing genes in Chinese families with retinitis pigmentosa.

Mutation Analysis of Pre-mRNA Splicing genes in Chinese Families with Autosomal Dominant Retinitis Pigmentosa.